FDA Targets Cancer Indications That Fail to Prove Benefit
US regulators are stepping up scrutiny of cancer indications that were granted an accelerated approval...
Health News 2 me
healthnews2me.com
Tag: Myeloma
FDA Targets Cancer Indications That Fail to Prove Benefit
US regulators are stepping up scrutiny of cancer indications that were granted an accelerated approval...
Phase 2b STORM Data Evaluating Selinexor in Patients with Penta-Refractory Multiple Myeloma Presented at the Society of Hematologic Oncology 2018 Annual Meeting
NEWTON, Mass., Sept. 13, 2018 (GLOBE NEWSWIRE) -- Karyopharm Therapeutics Inc. (Nasdaq:KPTI), a clinical-stage pharmaceutical...